Full description
This application predict the risk of progression from Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) for a new subject using demographic and biological features such as cognitive performance (e.g. MMSE score ≥27, indicating relatively preserved cognitive function despite MCI diagnosis), genetic risk factors (e.g. APOE4 positive status, which increases AD risk) and biomarker measurements (e.g. low Aβ value ≤44, suggesting lower levels of amyloid-beta protein)Available: 2025-06-03
Data time period: 2025-02-26 to 2027-02-27
Subjects
Alzheimer's disease |
Biomedical and Clinical Sciences |
Mild Cognitive Impairment |
Neurosciences |
Neurosciences Not Elsewhere Classified |
Predicting disease progression |
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Identifiers
- Handle : 102.100.100/701445
- URL : data.csiro.au/collection/csiro:64841
